Clinical Trials Logo

Treatment clinical trials

View clinical trials related to Treatment.

Filter by:
  • Not yet recruiting  
  • « Prev · Page 2

NCT ID: NCT04278261 Not yet recruiting - Prostate Cancer Clinical Trials

Comparison H-FIRE and Laparoscopic RP in Treating Men With Localized Prostate Cancer

Start date: July 1, 2022
Phase: N/A
Study type: Interventional

This trial is comparing the functional and oncological outcomes in treating men with prostate cancer between high-frequency irreversible electroporation and laparoscopic radical prostatectomy.

NCT ID: NCT04062370 Not yet recruiting - Clinical trials for Retinal Vein Occlusion

Ranibizumab Treatment for Macular Edema Secondary to Retinal Vein Occlusion

Start date: October 1, 2019
Phase: Phase 4
Study type: Interventional

Retinal vein occlusion (RVO) may lead to series of complications including retinal ischemia, macular edema (ME) and induce vision impairment. Intravitreal injection of Ranibizumab (0.5mg) has been proved to be a safe and effective method for the treatment of RVO-ME. In this study, different treatment regimens of Ranibizumab is applied and the effects is observed at 1-6 months to explore the best regimen for RVO. After 6 months, anti-VEGF therapy and/or laser photocoagulation is used to explore whether laser photocoagulation can maintain the therapeutic effect of Ranibizumab or reduce the injection number.

NCT ID: NCT03064386 Not yet recruiting - Treatment Clinical Trials

Comparative Study of Postieror Ankle Fracture

Start date: February 28, 2017
Phase: N/A
Study type: Interventional

To compare the clinical efficacy of open reduction and internal fixation (ORIF) with plate and screw for postieror malleolar fractures.

NCT ID: NCT02931136 Not yet recruiting - Clinical trials for Mild Cognitive Impairment

Early Diagnosis and Early Treatment of Alzheimer's Disease Based on Senile Plaque Imaging

Start date: November 2019
Phase: Phase 4
Study type: Interventional

The purpose of this study is based on the Flutemetamol-PET senile plaque imaging to investigate the peripheral blood biochemical and brain MRI imaging biomarkers and to research completely independent intellectual property rights neuropsychological test tool for the MCI due to AD. At the same time, the investigators will study the efficacy and safety of early treatment of MCI due to AD by Huperzine A in 52 weeks.

NCT ID: NCT01155297 Not yet recruiting - Clinical trials for Kidney Failure, Chronic

Effect of PT on QL, FC, PWV and Biochemical Markers in CRF on Conservative Treatment

Start date: June 2010
Phase: N/A
Study type: Interventional

Introduction: Chronic Kidney Disease (CKD) is considered an important public health problem, with prevalence of 9.6% in our population. The CKD has as main symptoms fatigue, muscle weakness and poor exercise tolerance, which directly contribute to physical inactivity and low mobility, increasing the risk of morbidity and mortality in CKD patients with significant impact on quality of life of these patients. Thus, patients with CKD have poor quality of life, high incidence of cardiovascular diseases, high prevalence of endothelial dysfunction, the consequent increase in arterial stiffness and serum concentration of asymmetric dimethylarginine (ADMA). It is believed that the conditioning of these patients may reduce cardiovascular risks and improve the quality of life. Aim of the study: Evaluate the impact of exercise training in relation to functional capacity, quality of life, pulse wave velocity and ADMA in patients with CKD on dialysis. Materials and methods: Is a randomized controlled study, with 34 CKD patients on conservative treatment, divided into control group (with stretching exercises and metabolic exercises) and training group, those undergoing physical training, aerobic and resistance during six months. Before and after exercise training, patients will be assessed using the SF-36 and IPAQ. Also be held assessment of pulse wave velocity, measurement of serum ADMA and spirometry testing. Statistical analysis consisted of t test for independent data or chi-square when appropriate.

NCT ID: NCT01057056 Not yet recruiting - Elderly Clinical Trials

The Role of Mind Body Therapy in Geriatric Rehabilitation

Start date: January 2010
Phase: Phase 1/Phase 2
Study type: Interventional

Background: The main goal of geriatric rehabilitation reconditioning following an acute illness is rapid restoration of normal activity. Key elements are pain control, restoration of bowel functions, sleep, appetite and general well-being, along side the physical activity. Objective: To assess the effect of mind-body intervention as an adjunct to medical and physical rehabilitation in geriatric patients. Design: Prospective study Setting: University affiliated large city general hospital